×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
PODD – insulet corporation (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
PODD
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
12/4
01:01 pm
podd
Insulet (NASDAQ:PODD) had its "buy" rating reaffirmed by analysts at Cowen Inc.
Low
Report
Insulet (NASDAQ:PODD) had its "buy" rating reaffirmed by analysts at Cowen Inc.
12/4
07:00 am
podd
Insulet Announces FDA 510(k) Clearance of Omnipod® 5 Algorithm Enhancements that Redefine Insulin Delivery and Simplify the Pod Experience
Low
Report
Insulet Announces FDA 510(k) Clearance of Omnipod® 5 Algorithm Enhancements that Redefine Insulin Delivery and Simplify the Pod Experience
12/2
04:52 pm
podd
Insulet: Excellent Business, Valuation Hurdle Remains [Seeking Alpha]
Low
Report
Insulet: Excellent Business, Valuation Hurdle Remains [Seeking Alpha]
11/26
08:01 am
podd
Artisan International Small-Mid Fund Q3 2025 Contrarianism Pays Off [Seeking Alpha]
Low
Report
Artisan International Small-Mid Fund Q3 2025 Contrarianism Pays Off [Seeking Alpha]
11/24
06:21 pm
podd
How the Narrative Around Insulet Is Evolving After Investor Day and New Analyst Targets [Yahoo! Finance]
Low
Report
How the Narrative Around Insulet Is Evolving After Investor Day and New Analyst Targets [Yahoo! Finance]
11/24
08:05 am
podd
Insulet (NASDAQ:PODD) was given a new $432.00 price target on by analysts at Canaccord Genuity Group Inc..
Low
Report
Insulet (NASDAQ:PODD) was given a new $432.00 price target on by analysts at Canaccord Genuity Group Inc..
11/24
07:19 am
podd
Insulet (NASDAQ:PODD) had its "buy" rating reaffirmed by analysts at Canaccord Genuity Group Inc..
Low
Report
Insulet (NASDAQ:PODD) had its "buy" rating reaffirmed by analysts at Canaccord Genuity Group Inc..
11/21
12:06 pm
podd
Insulet (NASDAQ:PODD) had its "outperform" rating reaffirmed by analysts at Sanford C. Bernstein.
Low
Report
Insulet (NASDAQ:PODD) had its "outperform" rating reaffirmed by analysts at Sanford C. Bernstein.
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
11/26
04:31 pm
podd
Form 144 INSULET CORP Filed by: Manea Dan
Low
Report
Form 144 INSULET CORP Filed by: Manea Dan
11/24
04:06 pm
podd
Form 144 INSULET CORP Filed by: Manea Dan
Low
Report
Form 144 INSULET CORP Filed by: Manea Dan
11/6
04:27 pm
podd
Form 10-Q INSULET CORP For: Sep 30
Low
Report
Form 10-Q INSULET CORP For: Sep 30
11/6
07:11 am
podd
Form 8-K INSULET CORP For: Nov 06
Low
Report
Form 8-K INSULET CORP For: Nov 06
11/3
05:36 pm
podd
Form 4 INSULET CORP For: Oct 31 Filed by: Huffines Robert Luther
Low
Report
Form 4 INSULET CORP For: Oct 31 Filed by: Huffines Robert Luther
11/3
05:33 pm
podd
Form 3 INSULET CORP For: Oct 31 Filed by: Huffines Robert Luther
Low
Report
Form 3 INSULET CORP For: Oct 31 Filed by: Huffines Robert Luther
10/30
03:17 pm
podd
Form SCHEDULE 13G/A INSULET CORP Filed by: VANGUARD GROUP INC
Low
Report
Form SCHEDULE 13G/A INSULET CORP Filed by: VANGUARD GROUP INC
10/23
07:19 am
podd
Form 8-K INSULET CORP For: Oct 21
Low
Report
Form 8-K INSULET CORP For: Oct 21
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
8/5
Insulet Reports Second Quarter 2019 Revenue of $177 Million, an Increase of 43% Year-Over-Year
21.4%
11/5 Form 8-K INSULET CORP For: Nov 05 10.5%
9/3 Form 8-K INSULET CORP For: Sep 03 9.4%
5/6 Insulet Co. (NASDAQ: PODD) was upgraded by analysts at BTIG Research from a "neutral" rating to a "buy" rating. They now have a $115.00 price target on the stock. 5.4%
2/26 Diabetes Stock Insulet Drops 8.5% on Earnings Miss and Softer-Than-Expected Outlook [The Motley Fool] 4.4%
4/6 Insulet to Announce First Quarter 2020 Financial Results on May 7, 2020 4.2%
1/6 Insulet to Announce Fourth Quarter and Full Year 2019 Financial Results on February 25, 2020 3.7%
9/24 Insulet Co. (NASDAQ: PODD) had its price target raised by analysts at Svb Leerink Llc from $160.00 to $185.00. They now have an "outperform" rating on the stock. 3.5%
2/26 Insulet Co. (NASDAQ: PODD) had its "outperform" rating re-affirmed by analysts at Raymond James. They now have a $205.00 price target on the stock, down previously from $213.00. 3.5%
2/27 Form 4 INSULET CORP For: Feb 26 Filed by: Benjamin Eric 3.4%
11/5 Form 8-K INSULET CORP For: Nov 05 10.5%
9/3 Form 8-K INSULET CORP For: Sep 03 9.4%
5/6 Insulet Co. (NASDAQ: PODD) was upgraded by analysts at BTIG Research from a "neutral" rating to a "buy" rating. They now have a $115.00 price target on the stock. 5.4%
2/26 Diabetes Stock Insulet Drops 8.5% on Earnings Miss and Softer-Than-Expected Outlook [The Motley Fool] 4.4%
4/6 Insulet to Announce First Quarter 2020 Financial Results on May 7, 2020 4.2%
1/6 Insulet to Announce Fourth Quarter and Full Year 2019 Financial Results on February 25, 2020 3.7%
9/24 Insulet Co. (NASDAQ: PODD) had its price target raised by analysts at Svb Leerink Llc from $160.00 to $185.00. They now have an "outperform" rating on the stock. 3.5%
2/26 Insulet Co. (NASDAQ: PODD) had its "outperform" rating re-affirmed by analysts at Raymond James. They now have a $205.00 price target on the stock, down previously from $213.00. 3.5%
2/27 Form 4 INSULET CORP For: Feb 26 Filed by: Benjamin Eric 3.4%
TOP News Decliners
2/25
Q4/2019 12/31/2019 EPS 0.080 ZacksConsensus 0.090 ActVsEst (0.010) - Miss
-8.5%
10/22 Insulet Co. (NASDAQ: PODD) is now covered by analysts at Stifel Nicolaus. They set a "hold" rating on the stock. -8.4%
7/31 Form 8-K INSULET CORP For: Jul 31 -5.7%
2/24 Form 4 INSULET CORP For: Feb 21 Filed by: Spears Michael P -5.1%
3/31 Insulet Co. (NASDAQ: PODD) was downgraded by analysts at Berenberg Bank from a "buy" rating to a "hold" rating. -5.0%
3/10 Form 4 INSULET CORP For: Mar 06 Filed by: Lemoine David A -4.7%
3/2 Insulet Provides Update on Pivotal Study of Omnipod Horizon™ -4.5%
3/2 Form 4 INSULET CORP For: Feb 27 Filed by: Spears Michael P -4.0%
9/4 Insulet prices upsized convertible debt offering [Seeking Alpha] -3.8%
4/6 Why Diabetes Stock Insulet Fell 13% in March [The Motley Fool] -3.6%
10/22 Insulet Co. (NASDAQ: PODD) is now covered by analysts at Stifel Nicolaus. They set a "hold" rating on the stock. -8.4%
7/31 Form 8-K INSULET CORP For: Jul 31 -5.7%
2/24 Form 4 INSULET CORP For: Feb 21 Filed by: Spears Michael P -5.1%
3/31 Insulet Co. (NASDAQ: PODD) was downgraded by analysts at Berenberg Bank from a "buy" rating to a "hold" rating. -5.0%
3/10 Form 4 INSULET CORP For: Mar 06 Filed by: Lemoine David A -4.7%
3/2 Insulet Provides Update on Pivotal Study of Omnipod Horizon™ -4.5%
3/2 Form 4 INSULET CORP For: Feb 27 Filed by: Spears Michael P -4.0%
9/4 Insulet prices upsized convertible debt offering [Seeking Alpha] -3.8%
4/6 Why Diabetes Stock Insulet Fell 13% in March [The Motley Fool] -3.6%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: